Comparison between morphologic and flow cytometric assessment of residual disease on day 19 of remission-induction therapy.

Each dot corresponds to the percentage of leukemic cells identified by morphologic analysis (x-axis) and by flow cytometry (y-axis) in bone marrow samples collected on day 19 from 248 children with newly diagnosed ALL